VuMedi Raises $104 Million Series B to Scale AI-Matched Physician Video Learning

VuMedi closed a $104 million Series B led by Oak HC/FT to expand the AI tool that matches doctors' clinical questions to expert video, now used by 150,000+ verified clinicians.

Key Takeaways

  • VuMedi raised a $104 million Series B led by Oak HC/FT, announced November 10, 2026.
  • The company's valuation and total prior funding were not disclosed.
  • More than 150,000 NPI-verified clinicians have used VuMedi's AI matching tool, generating over 1 million AI interactions since launch.
  • Physicians logged 56 million minutes of learning on the platform in the past 12 months, with AI users watching 122% more video than non-users.
  • VuMedi competes with Medscape, Doximity and UpToDate but differentiates through a video-first, AI-matched format.

A cardiologist stuck on an unusual arrhythmia case doesn't call a colleague on VuMedi anymore — the platform's AI tool pulls up the exact clip of a specialist explaining that pattern, drawn from a library spanning more than 21 medical specialties. VuMedi, the Oakland-based peer-to-peer physician learning company founded in 2008, announced on November 10, 2026 that it has closed a $104 million Series B led by Oak HC/FT. The company did not disclose a valuation or how much it had raised previously.

The round is a growth investment, not an early bet. VuMedi says it will use the money to push its AI matching tool into more specialties and keep adding to a video library that already spans dozens of clinical areas.

A Video Library Doctors Actually Finish Watching

VuMedi's core product is simple: clinical videos and podcasts recorded by specialist physicians for other physicians, covering everything from rare surgical techniques to new device workflows. Doctors use it the way they used to use a trusted colleague down the hall — to get unstuck on a specific case fast.

The AI layer the company is now scaling connects a clinician's exact question to the relevant few minutes of expert video, rather than forcing a search through a full-length lecture. More than 150,000 NPI-verified clinicians have used that tool since launch, generating over 1 million AI interactions.

The engagement data is what likely drew Oak HC/FT's check. Physicians logged 56 million minutes of learning on VuMedi in the past 12 months, with active users averaging more than 52 minutes a month on the platform. VuMedi says clinicians who use its AI tool watch 122% more video than those who don't, and the library grew by 20,000 new videos over the same stretch — a pace that suggests both rising physician demand and an aggressive content pipeline.

A Crowded Field, Won on Format

VuMedi competes for physician attention with Medscape, Doximity and UpToDate, all of which have bolted AI summarization or search onto older, text-heavy reference products. VuMedi's bet is that video, not text, is what clinicians retain under time pressure, and that an AI matcher trained on a proprietary video library is harder to clone than a chatbot layered over a database.

Business Wire reported the round without detailing how funds will split between AI development, content production and sales, or whether VuMedi plans new specialty verticals or international markets.

Oak HC/FT typically backs growth-stage healthcare and fintech companies rather than seed-stage bets, and a $104 million check size signals it sees VuMedi closer to scale-up than experiment. The firm's involvement also puts VuMedi in the company of other health-tech platforms chasing physician engagement as a wedge into broader clinical workflows, from continuing-education credit to point-of-care decision support.

What to watch next: whether VuMedi converts its AI engagement lift into partnerships with hospital systems or medical societies, which would diversify revenue beyond ad-hoc video views, and whether the 122% engagement gap holds as the clinician base grows past 150,000 and the platform pushes into specialties where video content is thinner today.

Category: Funding & Investments

Tags: Series B VuMedi Oak HC/FT AI in healthcare physician education clinical video

Related Articles

Frequently Asked Questions

How much did VuMedi raise and in what round?

VuMedi raised $104 million in a Series B round, announced November 10, 2026.

Who led VuMedi's Series B?

Oak HC/FT led the round. VuMedi did not disclose other participants or a valuation.

What does VuMedi's AI tool do?

It matches a physician's specific clinical question to the relevant segment of expert video from VuMedi's library, which spans more than 21 medical specialties.

How many clinicians use VuMedi?

More than 150,000 NPI-verified clinicians have used VuMedi's AI tool, generating over 1 million AI interactions since launch.

Who are VuMedi's competitors?

VuMedi competes with physician-facing platforms like Medscape, Doximity and UpToDate, which have added AI search or summarization to text-based reference products.